
It's a YES 💚 #Scotland decision-makers agree to fund Hyftor for facial angiofibromas in #TSC. This means that Hyftor will be available on #NHS Scotland for people with TSC aged over six years! More here: tuberous-sclerosis.org/scotl… #RareDisease #treatment










